Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
FDMT - CAPITAL EXPENDITURES
Capital Expenditures FDMT - 4D Molecular Therapeutics, Inc.
-2.77 M
LAST VALUE
44.85%
2 YEAR CAGR
-46.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR